ADIPOQ and metabolic syndrome: To our knowledge, this specific association has not been previously reported in women; however, it is consistent with the conclusion of a meta-analysis that proposed adiponectin as a diagnostic biomarker to identify subjects with metabolic syndrome, especially in high-risk populations with insulin resistance [20].